Verrica Pharmaceuticals Reports Second Quarter 2022 Financial Results

Go back to Verrica Pharmaceuticals Reports Second Quarter 2022 Financial Results
(NASDAQ: VRCA) Delayed: 5.41 +0.02 (0.37%)
Previous Close $5.39    52 Week High
Open $5.48    52 Week Low
Day High $5.63    P/E N/A 
Day Low $5.27    EPS
Volume 48,207